November 22, 2024

FDA Approves Bimzelx for Hidradenitis Suppurativa

Bimzelx is the first hidradenitis suppurativa treatment selectively targeting both interleukin-17A and interleukin-17F.

Conexiant

November 22, 2024

Trial Compares Two Therapies for Grief

Conexiant

November 21, 2024

Deuruxolitinib Shows Promise for Alopecia

Deuruxolitinib achieved significant hair regrowth in a Phase 3 clinical trial. 

Conexiant

November 21, 2024

Exercise Consistently Reduces Mortality Risk Across Lifespan

"The findings from this large international sample provide strong support for physical activity across all ages of the lifespan, and the benefits of physical activity appear to be sustained and may be enhanced with aging."

Conexiant

November 19, 2024

Mepivacaine May Ease IUD Pain for Nulliparous Women

Conexiant

November 19, 2024

Art-Based Training Improves Neurology Observational Skills

Conexiant

November 19, 2024

Processed Diets Linked to Reduced Sperm Quality

Each 10% increase in ultra-processed food intake is linked to a 1.5 million sperm reduction—could substituting whole foods improve outcomes?

Conexiant

November 18, 2024

Preconception Depression Tied to Infertility

Conexiant

November 18, 2024

Bladder Anticholinergics Tied to Dementia Risk

Conexiant